Literature DB >> 1680321

Beta-adrenoceptor-agonist and insulin actions on glucose metabolism in rat skeletal muscle in different thyroid states.

G D Dimitriadis1, S J Richards, M Parry-Billings, B Leighton, E A Newsholme, R A Challiss.   

Abstract

1. The actions of the beta-adrenoceptor agonist isoprenaline on glucose and glycogen metabolism, in the presence of various concentrations of insulin, were investigated in isolated soleus muscle preparations taken from eu-, hyper- and hypothyroid rats. 2. Hyperthyroidism, induced by 3,3',5-tri-iodo-D-thyronine (T3) administration for 5 days, increased the rate of lactate formation and suppressed the rate of glycogen synthesis in soleus muscle in response to isoprenaline, even in the presence of physiological or supraphysiological insulin concentrations. 3. Hypothyroidism, induced by administration of 6-n-propyl-2-thiouracil for 4 weeks, decreased the rate of isoprenaline-stimulated lactate formation at all insulin concentrations, but significantly decreased the responsiveness of lactate formation only at low insulin concentrations. In the presence of 100 or 10,000 mu-units of insulin/ml, the ability of isoprenaline to suppress the rate of glycogen synthesis was markedly impaired (inhibition at 100 mu-units of insulin/ml and 1 micro-M-isoprenaline: eu- 72.6 +/- 2.9%; hypo-41.0 +/- 2.1%; P less than 0.001). 4. Hyperthyroidism had no effect on the number or affinity of beta-adrenoceptors, defined by 125I-pindolol binding, or beta-adrenoceptor- or forskolin-stimulated adenylate cyclase activity in membrane preparations of gastrocnemius muscle, whereas hypothyroidism increased the beta-adrenoceptor density and decreased the beta-adrenoceptor-stimulated adenylate cyclase activity, without affecting the receptor affinity or forskolin-stimulated adenylate cyclase activity. 5. It is concluded that there is a complex interplay between insulin, catecholamines and thyroid hormones to regulate skeletal-muscle glucose metabolism. The changes observed in muscles in hypothyroidism may be explained, at least in part, by changes in beta-adrenoceptor-G-protein-adenylate cyclase coupling affecting the generation of cyclic AMP and the regulation of some of the key enzymes of glycogen metabolism; in contrast, the changes observed in muscles in hyperthyroidism do not appear to result from alterations at the level of the receptor-mediated second-messenger generation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680321      PMCID: PMC1151384          DOI: 10.1042/bj2780587

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

Review 1.  Permissive hormone regulation of hormone-sensitive effector systems.

Authors:  C C Malbon; P J Rapiejko; D C Watkins
Journal:  Trends Pharmacol Sci       Date:  1988-01       Impact factor: 14.819

2.  Effects of hyperthyroidism on the sensitivity of glycolysis and glycogen synthesis to insulin in the soleus muscle of the rat.

Authors:  G D Dimitriadis; B Leighton; I G Vlachonikolis; M Parry-Billings; R A Challiss; D West; E A Newsholme
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

3.  Insulin stimulates dephosphorylation of phosphorylase in rat epitrochlearis muscles.

Authors:  J N Zhang; J Hiken; A E Davis; J C Lawrence
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

4.  Increased fat and skeletal muscle beta-adrenergic receptors but unaltered metabolic and hemodynamic sensitivity to epinephrine in vivo in experimental human thyrotoxicosis.

Authors:  S B Liggett; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

Review 5.  The structure and regulation of protein phosphatases.

Authors:  P Cohen
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

6.  Effects of the beta-adrenoceptor agonist isoprenaline on insulin-sensitivity in soleus muscle of the rat.

Authors:  R A Challiss; F J Lozeman; B Leighton; E A Newsholme
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

7.  Glucose and free fatty acid turnover in thyrotoxicosis and hypothyroidism, before and after treatment.

Authors:  J Saunders; S E Hall; P H Sönksen
Journal:  Clin Endocrinol (Oxf)       Date:  1980-07       Impact factor: 3.478

8.  Coupled diminished energy turnover and phosphorylase a formation in contracting hypothyroid rat muscle.

Authors:  W J Leijendekker; C van Hardeveld; A A Kassenaar
Journal:  Metabolism       Date:  1985-05       Impact factor: 8.694

9.  Effects of altered thyroid status on beta-adrenergic actions on skeletal muscle glycogen metabolism.

Authors:  D T Chu; H Shikama; B S Khatra; J H Exton
Journal:  J Biol Chem       Date:  1985-08-25       Impact factor: 5.157

10.  Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans.

Authors:  G Dimitriadis; B Baker; H Marsh; L Mandarino; R Rizza; R Bergman; M Haymond; J Gerich
Journal:  Am J Physiol       Date:  1985-05
View more
  5 in total

1.  Comparative effects of the endogenous agonist glucagon-like peptide-1 (GLP-1)-(7-36) amide and the small-molecule ago-allosteric agent "compound 2" at the GLP-1 receptor.

Authors:  Karen Coopman; Yan Huang; Neil Johnston; Sophie J Bradley; Graeme F Wilkinson; Gary B Willars
Journal:  J Pharmacol Exp Ther       Date:  2010-05-27       Impact factor: 4.030

2.  Regulation of glycogen synthesis in rat skeletal muscle after glycogen-depleting contractile activity: effects of adrenaline on glycogen synthesis and activation of glycogen synthase and glycogen phosphorylase.

Authors:  J Franch; R Aslesen; J Jensen
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

3.  Smoothelin-Like Protein 1 Regulates Development and Metabolic Transformation of Skeletal Muscle in Hyperthyroidism.

Authors:  Evelin Major; Ferenc Győry; Dániel Horváth; Ilka Keller; István Tamás; Karen Uray; Péter Fülöp; Beáta Lontay
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-05       Impact factor: 5.555

4.  Allosteric modulation of the activity of the glucagon-like peptide-1 (GLP-1) metabolite GLP-1 9-36 amide at the GLP-1 receptor.

Authors:  Naichang Li; Jing Lu; Gary B Willars
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

5.  Insulin resistance and its correlation with chemerin and visfatin in Saudi patients with hyperthyroidism.

Authors:  Huda A Al Doghaither; Eman M Alshaikh; Ulfat M Omar; Hadeil M Alsufiani; Rasha A Mansouri; Nesrin I Tarbiah; Abdelrhman A Alshaikh; Afnan M Alshaikh
Journal:  Int J Health Sci (Qassim)       Date:  2019 Sep-Oct
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.